Other highlights in the March 15 JNCI

Dietary Folate Intake Associated with Reduced Pancreatic Cancer Risk

High dietary folate intake may be associated with a reduced risk of pancreatic cancer, a new study suggests. However, supplemental folate intake was not associated with pancreatic cancer risk.

Susanna C. Larsson, M.Sc., of the Karolinska Institute in Stockholm, Sweden, and colleagues gave a food and diet questionnaire to 81,922 cancer-free men and women enrolled in the Swedish Mammography Cohort and Cohort of Swedish Men. They followed these men and women for an average of 6.8 years, and observed 135 cases of pancreatic cancer during that time.

Men and women whose dietary intake of folate was equal to or above 350 micrograms a day had a lower incidence of pancreatic cancer than men and women whose dietary intake of folate was less than 200 micrograms a day. They calculated that there would be 41 cases per 100,000 people who consumed the lowest amounts of folate and 18 cases per 100,000 people among those consuming the most folate. The authors suggest increased dietary folate intake may be associated with a reduced risk of pancreatic cancer.

Contact: Susanna Larsson, Karolinska Institute, 46-8-524-860-59, susanna.larsson@ki.se

Study Examines Childhood Leukemia Incidence and Its Association with Influenza

A new study has found that small peaks in the annual rates of childhood acute lymphoblastic leukemia (ALL) in Britain immediately followed influenza epidemics. The finding supports the hypothesis that some childhood leukemia may be triggered by an infection occurring close to the time of diagnosis.

Mary Kroll, M.Sc., and colleagues at Oxford University, studied time trends of childhood leukemia diagnosed from 1974-2000 in England, Scotland, and Wales, using data from the National Registry of Childhood Tumors.

There was a gradual increase in the incidence of childhood ALL bet

Contact: Ariel Whitworth
Journal of the National Cancer Institute

Page: 1 2 3

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights from the July 10 JNCI
4. Other highlights in JNCI, June 26
5. Other highlights in JNCI, June 12
6. Other highlights from the June 6 JNCI
7. Other highlights in the May 16 JNCI
8. Other highlights from the April 18 Journal of the National Cancer Institute
9. Other highlights from the March 21 JNCI
10. Other highlights in the March 7 JNCI
11. Other highlights in the Feb. 21 JNCI

Post Your Comments:

(Date:3/9/2019)... ... March 09, 2019 , ... ... hM4Di ligands – exciting compounds for scientists studying GPCR and DREADD signalling. Hello ... and the National Institute of Neurological Disorders and Stroke, both institutes of the ...
(Date:2/27/2019)... ... 2019 , ... Fluxion Biosciences, a leading developer of precision solutions for life ... grant for further development of its ERASE-Seq liquid biopsy technology. The Phase I grant ... Dr. Omar Mian at the Cleveland Clinic. , Liquid biopsies offer the potential to ...
(Date:2/22/2019)... ... February 20, 2019 , ... ... precision medicine, the traditional line between engineering and medical science grows ever thinner. ... smarter, the medical device industry is making medical practice easier for doctors, more ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... ... in Israel and the Middle East region, and Swiss-based CDMO Lonza announced ... platform. The partnership will enable Sheba to vastly streamline its in-house cell ...
(Date:3/14/2019)... PRINCETON, N.J. (PRWEB) , ... March 14, 2019 , ... ... will create challenges for companies to keep up. Traditional Regulatory intelligence ... times and adapting technology to get global Regulatory teams right Insights faster and cheaper. ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... gold standard solution for preclinical research organizations. It is a low code, ... connected systems and facilities, innovative technology-driven automated data capture and seamless data ...
(Date:3/9/2019)... SAN DIEGO (PRWEB) , ... March 07, 2019 ... ... Agilent Technologies, is a pioneer in the development and commercialization of high performance, ... and PhysioStim, a leading European CRO with GLP-certified expertise in cardiovascular pharmacology and ...
Breaking Biology Technology:
Cached News: